Abstract
The opioid system modulates several physiological processes, including analgesia, the stress response, the immune response and neuroendocrine function1. Pharmacological and molecular cloning studies have identified three opioid-receptor types, δ, κ and µ, that mediate these diverse effects2,3. Little is known about the ability of the receptors to interact to form new functional structures, the simplest of which would be a dimer. Structural and biochemical studies show that other G-protein-coupled receptors (GPCRs) interact to form homodimers4,5. Moreover, two non-functional receptors heterodimerize to form a functional receptor, suggesting that dimerization is crucial for receptor function6,7,8,9,10,11. However, heterodimerization between two fully functional receptors has not been documented. Here we provide biochemical and pharmacological evidence for the heterodimerization of two fully functional opioid receptors, κ and δ. This results in a new receptor that exhibits ligand binding and functional properties that are distinct from those of either receptor. Furthermore, the κ–δ heterodimer synergistically binds highly selective agonists and potentiates signal transduction. Thus, heterodimerization of these GPCRs represents a novel mechanism that modulates their function.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Herz, A. Opioids Vol. 1(Springer, Berlin, 1993).
Miotto, K., Magendzo, K. & Evans, C. J. in The Pharmacology of Opioid Peptides(ed. Tseng, L.) 57–71 (Harwood, Singapore, 1995).
Kieffer, B. L. Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell. Mol. Neurobiol. 15, 615–635 ( 1995).
Hebert, T. E. & Bouvier, M. Structural and functional aspects of G protein-coupled receptor oligomerization. Biochem. Cell Biol. 76, 1–11 (1998 ).
Gouldson, P. R., Snell, C. R., Bywater, R. P., Higgs, C. & Reynolds, C. A. Domain swapping in G-protein coupled receptor dimers. Protein Eng. 11, 1181–1193 (1998).
Maggio, R., Vogel, Z. & Wess, J. Co-expression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular cross-talk between G-protein-linked receptors. Proc. Natl Acad. Sci. USA 90, 3103– 3107 (1993).
Monnot, C. et al . Polar residues in the transmembrane domains of the type I angiotensin II receptor are required for binding and coupling: Reconstitution of the binding site by co-expression of two deficient mutants. J. Biol. Chem. 271, 1507–1513 ( 1996).
Jones, K. A. et al . GABAB receptors function as a heteromeric assembly fo the subunits GABABR1 and GABABR2. Nature 396, 674–679 ( 1998).
Kaupmann, K. et al . GABAB-receptor subtypes assemble into functional heteromeric complexes. Nature 396, 683– 687 (1998).
White, J. H. et al . Heterodimerization is required for the formation of a functional GABAB receptor. Nature 396, 679 –682 (1998).
Kuner, R. et al . Role of heteromer formation in GABAB receptor function. Science 283, 74–77 (1999).
Cvejic, S. & Devi, L. Dimerization of the delta opioid receptor; implications for a function in receptor internalization. J. Biol. Chem. 272, 26959–26964 ( 1997).
Romano, C., Yang, W. & O'Malley, K. Metabotropic glutamate receptor 5 is a disulfide-linked dimer. J. Biol. Chem. 271, 28612– 28616 (1996).
Bai, M., Trivedi, S. & Brown, E. M. Dimerization of the extracellular calcium-sensing receptor on the cell surface of CaR-transfected HEK-293 cells. J. Biol. Chem. 273, 23605–23610 (1998).
Trapaidze, N., Keith, D. E., Cvejic, S., Evans, C. J. & Devi, L. A. Sequestration of the delta opioid receptor: Role of the C terminus in agonist-mediated internalization. J. Biol. Chem. 271, 29279–29285 ( 1996).
Keith, D. E. et al . Morphine activates opioid receptors without causing their rapid internalization. J. Biol. Chem. 271, 19021–19024 (1996).
Chu, P., Murray, S., Lissin, D. & von Zastrow, M. Delta and kappa opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist. J. Biol. Chem. 272, 27124–27130 (1997).
Lahti, R. A., Mickelson, M. M., McCall, J. M. & Von Voigtlander, P. [3H]U-69593, a highly selective ligand for the opioid κ receptor. Eur. J. Pharmacol. 109, 281– 284 (1985).
Roth, G. et al . [D-Pen2,D-Pen5]enkephalin analogues with increased affinity and selectivity for δ opioid receptors. J. Med. Chem. 258, 299–303 (1990).
Portoghese, P. S., Lipkowski, A. W. & Takemori, A. E. Binaltrophimine and norbinaltrophimine, potent and selective κ-opioid receptor antagonists. Life Sci. 40, 1287–1292 (1987).
Schiller, P. et al . TIPPΨ: A highly potent and stable pseudopeptide δ opioid receptor antagonist with extraordinary δ selectivity. J. Med. Chem. 36, 3182–3187 (1993).
Zukin, R. S., Echbali, M., Olive, D., Unterwald, E. M. & Tempel, A. Characterization and visualization of rat and guinea pig brain κ opioid receptors: Evidence for κ1 and κ 2 opioid receptors. Proc. Natl Acad. Sci. USA 4061–4065 (1988).
Nock, B. in The Pharmacology of Opioid Peptides(ed. Tseng, L.) 29– 56 (Harwood, Singapore, 1995).
Traynor, J. R. & Elliott, J. Delta opioid receptor subtypes and cross talk with mu receptors. Trends Pharmacol. Sci. 14, 84–86 ( 1993).
Zaki, P. A. et al . Opioid receptor types and subtypes: the delta receptor as a model. Annu. Rev. Pharmacol. Toxicol. 36, 379–401 (1996).
Jordan, B. & Devi, L. A. Molecular mechanisms of opiate receptor signal transduction. Br. J. Anaesth. 81, 12–19 (1998).
Lord, J. A. H., Waterfield, A. A., Hughes, J. & Kosterlitz, H. W. Endogenous opioid peptides: Multiple agonists and receptors. Nature 267, 495–499 ( 1977).
Cvejic, S., Trapaidze, N., Cyr, C. & Devi, L. A. Thr353, located within the COOH-terminal tail of the delta opiate receptor, is involved in receptor down-regulation. J. Biol. Chem. 271, 4073–4076 (1996).
Cheng, Y. C. & Prusoff, W. H. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzyme reaction. Biochem. Pharmacol. 22, 3099–3102 ( 1973).
Polakiewicz, R., Schieferl, S. M., Dorner, L. F., Kansra, V. & Comb, M. J. Amitogen-activated protein kinase pathway is required for mu-opioid receptor desensitization. J. Biol. Chem. 273, 12402–12406 (1998).
Acknowledgements
We thank L. Fricker and S. Cvejic for critical reading of the manuscript and P.Schiller for the gift of TIPPΨ. This work is supported in part by grants from the NIH (NIDA and NINDS).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jordan, B., Devi, L. G-protein-coupled receptor heterodimerization modulates receptor function . Nature 399, 697–700 (1999). https://doi.org/10.1038/21441
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/21441
This article is cited by
-
Structural basis of dimerization of chemokine receptors CCR5 and CXCR4
Nature Communications (2023)
-
Heterodimerization of cholecystokinin 1 and cholecystokinin 2 receptors in gallbladder cancer: a new mechanism for carcinogenesis
Journal of Cancer Research and Clinical Oncology (2023)
-
Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer
Communications Biology (2021)
-
Kappa but not delta or mu opioid receptors form homodimers at low membrane densities
Cellular and Molecular Life Sciences (2021)
-
Single-molecule analysis reveals agonist-specific dimer formation of µ-opioid receptors
Nature Chemical Biology (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.